Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Effectiveness of systemic voriconazole in reducing post-surgical recurrence of aspergillus mycotic rhinosinusitis.

View through CrossRef
Objective: To determine voriconazole efficacy in postoperative FESS patients to prevent or minimize recurrence of Aspergillus associated rhinosinusitis. Study Design: Observational Prospective Analytical. Setting: Department of ENT and Head & Neck Surgery, KRL Hospital Islamabad. Period: 01.07.2021 to 30.06.2022. Methods: 57 patients (selected by simple random sampling technique) who underwent FESS for mycotic disease caused by Aspergillus species were followed prospectively as per the department’s follow up protocols while receiving post-operative voriconazole. The initial dose and duration of oral drug advised depended on the severity and extent of disease at the time of surgery and the dose was adjusted on subsequent OPD reviews based on endoscopic nasal examination findings, visual analogue score for total nasal sinus symptoms as well as radiological findings where necessary. The success of treatment was monitored to check the efficacy of voriconazole in preventing post-surgical recurrence and the importance of response-based dose adjustments in patients suffering from mycotic rhinosinusitis. Data analysis was done using SPSS version 20. Results: Among 57 patients (mean age 32 years), systemic voriconazole after FESS showed high efficacy, with 89.5% remaining relapse-free at one year. Only six patients (10.5%) developed recurrence, mostly after tapering therapy, and three (5.3%) discontinued treatment due to adverse effects or noncompliance. Serial VAS, CT, and endoscopy scores demonstrated progressive improvement, with 35.1% achieving complete recovery by 12 weeks. Conclusion: We would like to conclude that voriconazole has proven highly effective in the treatment of sinonasal aspergillosis and has been proven to be the drug of choice to compliment thorough surgical clearance. Re-administration of voriconazole may be warranted at the slightest hint of recurrence noted on nasal endoscopic or radiological examination which may need to be biopsy proven.
Title: Effectiveness of systemic voriconazole in reducing post-surgical recurrence of aspergillus mycotic rhinosinusitis.
Description:
Objective: To determine voriconazole efficacy in postoperative FESS patients to prevent or minimize recurrence of Aspergillus associated rhinosinusitis.
Study Design: Observational Prospective Analytical.
Setting: Department of ENT and Head & Neck Surgery, KRL Hospital Islamabad.
Period: 01.
07.
2021 to 30.
06.
2022.
Methods: 57 patients (selected by simple random sampling technique) who underwent FESS for mycotic disease caused by Aspergillus species were followed prospectively as per the department’s follow up protocols while receiving post-operative voriconazole.
The initial dose and duration of oral drug advised depended on the severity and extent of disease at the time of surgery and the dose was adjusted on subsequent OPD reviews based on endoscopic nasal examination findings, visual analogue score for total nasal sinus symptoms as well as radiological findings where necessary.
The success of treatment was monitored to check the efficacy of voriconazole in preventing post-surgical recurrence and the importance of response-based dose adjustments in patients suffering from mycotic rhinosinusitis.
Data analysis was done using SPSS version 20.
Results: Among 57 patients (mean age 32 years), systemic voriconazole after FESS showed high efficacy, with 89.
5% remaining relapse-free at one year.
Only six patients (10.
5%) developed recurrence, mostly after tapering therapy, and three (5.
3%) discontinued treatment due to adverse effects or noncompliance.
Serial VAS, CT, and endoscopy scores demonstrated progressive improvement, with 35.
1% achieving complete recovery by 12 weeks.
Conclusion: We would like to conclude that voriconazole has proven highly effective in the treatment of sinonasal aspergillosis and has been proven to be the drug of choice to compliment thorough surgical clearance.
Re-administration of voriconazole may be warranted at the slightest hint of recurrence noted on nasal endoscopic or radiological examination which may need to be biopsy proven.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Effects of inflammation on voriconazole metabolism and peripheral blood trough concentration
Effects of inflammation on voriconazole metabolism and peripheral blood trough concentration
Abstract Background The inner association of inflammation with voriconazole (VCZ) metabolism has not been fully investigated. This study further discussed the relationship...
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Efavirenz 400 mg q24 h reduces exposure to voriconazole 200 mg q12 h when the two drugs are co‐administered.• Furthermore, voriconazole i...
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED]Keanu Reeves CBD Gummies ==❱❱ Huge Discounts:[HURRY UP ] Absolute Keanu Reeves CBD Gummies (Available)Order Online Only!! ❰❰= https://www.facebook.com/Keanu-Reeves-CBD-G...
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract Introduction Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
Impact ofCYP2C19,CYP3A4,ABCB1, andFMO3genotypes on plasma voriconazole in Thai patients with invasive fungal infections
Impact ofCYP2C19,CYP3A4,ABCB1, andFMO3genotypes on plasma voriconazole in Thai patients with invasive fungal infections
AbstractVoriconazole is the first‐line antifungal choice in the treatment of invasive fungal infections (IFIs). Single nucleotide polymorphisms (SNPs) in drug‐metabolizing and tran...
FUNGI YANG BERPOTENSI PENGHASIL AFLATOKSIN PADA BUNGKIL KACANG
FUNGI YANG BERPOTENSI PENGHASIL AFLATOKSIN PADA BUNGKIL KACANG
The research were done to find out many kinds of fungi which contaminate on pressed peanut cake during storage. Pressed peanut cake 15 days old were stored in plastic sack, every 1...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract Introduction  Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...

Back to Top